MedTrace Logo

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

NCT02516969 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2022-01-14

Study results available
· View outcomes & findings →

Summary

Comparison of patients with operable, recurrent previously-irradiated squamous cell head-and-neck cancers with or without adjuvant SBRT.

Conditions

Interventions

RADIATION

Stereotactic Body Radiotherapy

Radiation

Sponsors & Collaborators

  • David A. Clump, MD, PhD

    lead OTHER

Principal Investigators

  • David A Clump, MD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-05-30
Completion
2021-08-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02516969 on ClinicalTrials.gov